Arrhythmia
Conditions
Interventions
Treatment group:Wushen Oral Liquid combined with metoprolo
Control group:metoprolo
Sponsors
Shuguang Hospital affiliated to Shanghai University of TCM
Eligibility
Sex/Gender
All
Age
25 Years to 85 Years
Inclusion criteria
Inclusion criteria: Myocardial infarction meets the relevant criteria in "Practical Internal Medicine" and the 2019 Chinese Medical Association "Primary Diagnosis and Treatment Guidelines for ST-Segment Elevation Myocardial Infarction". The diagnosis of ventricular premature contraction meets the relevant criteria in the "Chinese Expert Consensus on Ventricular Arrhythmias Primary Version" of the Chinese Society of Cardiac Pacing and Electrophysiology in 2022, and the severity of the condition is graded according to Myerburg frequency =3 and morphology A-C; Aged 25 to 85, gender unrestricted; Acute phase undergoing PCI for revascularization; Disease duration from 2 weeks to 2 years after myocardial infarction; During the clinical observation period, the subjects will stop taking any other similar Chinese herbal medicine or proprietary Chinese medicine; The subjects voluntarily participate in this study, are able to cooperate with clinical observation, and sign a written informed consent form; Subjects who have not participated in any drug clinical trials in the 3 months before enrollment.
Exclusion criteria
Exclusion criteria: Severe primary arrhythmia, severe cardiopulmonary insufficiency, severe neurocirculatory dystonia, and hyperthyroidism; Severe hypertension, severe cardiopulmonary insufficiency (heart failure NYHA grade IV); Poorly controlled severe primary diseases of the liver, kidney, endocrine, respiratory, hematopoietic systems, etc.; Severe infections and advanced malignant tumors; Pregnant or lactating women; Individuals with known allergies or hypersensitivity to the components of the test drug.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| QT dispersion; | — |
Secondary
| Measure | Time frame |
|---|---|
| The number of premature ventricular beats;Heart rate variability;TNF-a;IL-6;hs-CRP;NO;TCM syndrome score; | — |
Countries
China
Contacts
Public ContactTao Liyu
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Outcome results
None listed